So from that point of view in the sense, of course, we expect it to be neutral or maybe slightly better but more or less neutral. On the ma...

Investors are keenly watching a panel discussion of central bankers in Sintra, including European Central Bank President Christine Lagarde,...

"Our strategy for India in pharmaceuticals is to continue to make significant investments, we believe that India is a growing market with a...

Investors are also awaiting the U.S. August inflation report next week for fresh clues on whether the Federal Reserve will hike rates by ha...

The biosimilars planned under this agreement include biosimilar Prolia (denosumab 60mg/ml) and Xgeva (denosumab 70 mg/ml) for treating oste...

Listed pharmaceutical entity Shilpa Medicare on Monday informed the exchanges that its subsidiary Shilpa Biologicals (SBPL) has received a ...

"The spirit of partnership in this joint venture has all been about channelling the core strengths of both Zydus and Bayer for the benefit ...

"Asia Pacific is the fastest growing region for Bayer's pharmaceuticals sales globally. We are very interested and committed to India and a...

“India is a large market and we will get through the challenges that are there. It is never easy but we also see huge potential in the Indi...

Novartis won an important endorsement of its new medicine for chronic lung disease when European regulators recommended approval of Ultibro...